SEriT BY:tfACnTLL UfTO-N : ^ - 1 5 - 3 3 Ml): 43AM : fiACHTELL
UPTON- 5453297;
K E M 0 3 U O M
Apri l 2B, 1992
TO: Herbert K. Wachtal l Paul Vizcarrondo , J r . John r ,
5avarese
FROH: D a v i d M. Murphy
RE: LORIIXARD/CTR INQUIRY
Yesterday at Lorlllard (HY) a new issue can* up that we should
discuss as scon as possible.
Art Stevens end Bill Allinder would like our view on whether,
given WLRAX's moratorium advice. Lorillard may participate in
funding through a Shook, Hardy special account the work of a
Georgetown pathologist, Bennett Jensen.
According to Allinder, the facts are as follows: Dr." Jensen
received **CTR Speelal Project" funds back in '84, which funds have
been spent. He now faces funding problems at Georgetown that, again
according to Allinder, have something to do with his ties to the
industry. Because of his worsening relations with Georgetown,
Jensen is looking for a position at another university and could
use some funds to tide bin over until he finds a new home.
Shook, Hardy proposes to Mgive hia" 340,000 not for specific
research (he's currently working on a vaccine for human patholoma)
or with an eye to publication but solely in order to maintain a
good relationship with hin and secure his continued help in making
contact with other scientists. The money would coma from an expert
witness fund administered by Shook, Hardy ("Shook, Hardy special
Fund").
Ordinarily, each tobacco company contributes to the shook. Hardy
fund and thereafter is not involved in deciding whether to approve
specific litigation or legislation related expenditures. This
expenditure, however, was brought to Art Stevens' attention by
Alllnder because it could be construed _ to violate HMW's
moratorium on new special projects funding, *j
